Risk assessment according to IPSS-M is superior to AML ELN risk classification in MDS/AML overlap patients defined by ICC.
作者信息
Huber Sandra, Baer Constance, Hutter Stephan, Dicker Frank, Fuhrmann Irene, Meggendorfer Manja, Pohlkamp Christian, Kern Wolfgang, Haferlach Torsten, Haferlach Claudia, Hoermann Gregor
机构信息
MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, 81377, Munich, Germany.
出版信息
Leukemia. 2023 Oct;37(10):2138-2141. doi: 10.1038/s41375-023-02004-w. Epub 2023 Aug 12.
Abstract
摘要
Zotero 插件